Accordingly, in this study, we focused on PTHrP, a potent activator of osteoclastic bone resorption, as an EGR4-downstream gene to clarify the pathophysiological role of EGR4 as a transcription factor in SCLC bone metastases. Here, EGR4 is linked to small cell lung carcinoma.